Heterologous expression of the membrane proteins that control cellular excitability
- PMID: 7678529
- DOI: 10.1007/978-3-0348-7265-2_2
Heterologous expression of the membrane proteins that control cellular excitability
Abstract
Versatile and potent expression systems are needed to decipher the structure and functions of the many excitability proteins that have been identified through molecular cloning. This article reviews the use of recombinant vaccinia viruses (VV), which have been recently explored for the heterologous expression of eukaryotic proteins. Vaccinia viruses feature a series of favourable properties, most of all a broad host range and high efficiency of infection, that make them uniquely suited as flexible expression vectors. In one type of experiment, the recombinant virus simply harbors the cDNA for the foreign protein; in a second type the virus harbors the cDNA for the specific and efficient RNA polymerase of bacteriophage T7, which in turn generates RNA from a separate introduced plasmid or virus. Both variations have been successfully applied to the expression and analysis of voltage-dependent ion channels, neurotransmitter receptors and other excitability proteins in many cell lines and postmitotic cells in culture. VV vectors promise to be particularly useful to study membrane proteins that require posttranslational processing, association with cell-specific subunits or coupling to endogenous second messengers pathways.
Similar articles
-
Transient and inducible expression of vaccinia/T7 recombinant viruses.Methods Mol Biol. 2004;269:41-50. doi: 10.1385/1-59259-789-0:041. Methods Mol Biol. 2004. PMID: 15114006 Review.
-
A vaccinia virus MVA-T7-mediated recovery of infectious hepatitis A virus from full-size cDNA or from two cDNAs, both by themselves unable to complete the virus life cycle.Virus Res. 2002 Oct;89(1):75-88. doi: 10.1016/s0168-1702(02)00115-6. Virus Res. 2002. PMID: 12367752
-
Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal.J Virol Methods. 2000 Mar;85(1-2):1-10. doi: 10.1016/s0166-0934(99)00147-0. J Virol Methods. 2000. PMID: 10716333
-
Enhanced genetic rescue of negative-strand RNA viruses: use of an MVA-T7 RNA polymerase vector and DNA replication inhibitors.J Virol Methods. 2003 Jul;111(1):29-36. doi: 10.1016/s0166-0934(03)00132-0. J Virol Methods. 2003. PMID: 12821194
-
Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.Methods Mol Biol. 2004;269:31-40. doi: 10.1385/1-59259-789-0:031. Methods Mol Biol. 2004. PMID: 15114005 Review.
Cited by
-
Expression of hepatitis E virus putative structural proteins in recombinant vaccinia viruses.Clin Diagn Lab Immunol. 1994 Mar;1(2):253-6. doi: 10.1128/cdli.1.2.253-256.1994. Clin Diagn Lab Immunol. 1994. PMID: 7496958 Free PMC article.